Published in Lancet on July 12, 1997
Aggresomes: a cellular response to misfolded proteins. J Cell Biol (1998) 11.24
Translational control in the endoplasmic reticulum stress response. J Clin Invest (2002) 4.56
Characterization and dynamics of aggresome formation by a cytosolic GFP-chimera. J Cell Biol (1999) 4.06
p62 Is a common component of cytoplasmic inclusions in protein aggregation diseases. Am J Pathol (2002) 3.80
Cytoplasmic penetration and persistent infection of mammalian cells by polyglutamine aggregates. Nat Cell Biol (2009) 3.55
Chemical chaperones mediate increased secretion of mutant alpha 1-antitrypsin (alpha 1-AT) Z: A potential pharmacological strategy for prevention of liver injury and emphysema in alpha 1-AT deficiency. Proc Natl Acad Sci U S A (2000) 3.17
Stabilities and conformations of Alzheimer's beta -amyloid peptide oligomers (Abeta 16-22, Abeta 16-35, and Abeta 10-35): Sequence effects. Proc Natl Acad Sci U S A (2002) 3.06
A survival pathway for Caenorhabditis elegans with a blocked unfolded protein response. J Cell Biol (2002) 2.72
In situ atomic force microscopy study of Alzheimer's beta-amyloid peptide on different substrates: new insights into mechanism of beta-sheet formation. Proc Natl Acad Sci U S A (1999) 2.24
An overview of the serpin superfamily. Genome Biol (2006) 2.14
Neutrophil elastase, proteinase 3, and cathepsin G as therapeutic targets in human diseases. Pharmacol Rev (2010) 1.97
Chaperone-dependent amyloid assembly protects cells from prion toxicity. Proc Natl Acad Sci U S A (2008) 1.88
Liver injury in alpha1-antitrypsin deficiency: an aggregated protein induces mitochondrial injury. J Clin Invest (2002) 1.84
Protein homeostasis and aging in neurodegeneration. J Cell Biol (2010) 1.76
Proteotoxicity in the endoplasmic reticulum: lessons from the Akita diabetic mouse. J Clin Invest (2002) 1.66
Molecular dynamics simulations of alanine rich beta-sheet oligomers: Insight into amyloid formation. Protein Sci (2002) 1.59
Heat shock protein 90 modulates the unfolded protein response by stabilizing IRE1alpha. Mol Cell Biol (2002) 1.54
Generic hydrophobic residues are sufficient to promote aggregation of the Alzheimer's Abeta42 peptide. Proc Natl Acad Sci U S A (2006) 1.44
Transmission of prions. Proc Natl Acad Sci U S A (2002) 1.36
The protein translocation channel binds proteasomes to the endoplasmic reticulum membrane. EMBO J (2005) 1.31
Medin: an integral fragment of aortic smooth muscle cell-produced lactadherin forms the most common human amyloid. Proc Natl Acad Sci U S A (1999) 1.24
Guiding protein aggregation with macromolecular crowding. Biochemistry (2008) 1.23
Aggregation of γ-crystallins associated with human cataracts via domain swapping at the C-terminal β-strands. Proc Natl Acad Sci U S A (2011) 1.21
Young onset dementia. Postgrad Med J (2004) 1.20
The intracellular accumulation of polymeric neuroserpin explains the severity of the dementia FENIB. Hum Mol Genet (2008) 1.20
Cleaved antitrypsin polymers at atomic resolution. Protein Sci (2000) 1.17
Genetics and respiratory disease. 2. Alpha 1-antitrypsin deficiency, cirrhosis and emphysema. Thorax (1998) 1.17
Familial encephalopathy with neuroserpin inclusion bodies. Am J Pathol (1999) 1.16
Endoplasmic reticulum-associated degradation (ERAD) and autophagy cooperate to degrade polymerogenic mutant serpins. J Biol Chem (2009) 1.14
A cellular perspective on conformational disease: the role of genetic background and proteostasis networks. Curr Opin Struct Biol (2010) 1.13
Update of the human and mouse SERPIN gene superfamily. Hum Genomics (2013) 1.12
The ubiquitin-proteasome system in neurodegenerative diseases: precipitating factor, yet part of the solution. Front Mol Neurosci (2014) 1.10
The lens in hereditary hyperferritinaemia cataract syndrome contains crystalline deposits of L-ferritin. Br J Ophthalmol (2000) 1.10
Engineering metal ion coordination to regulate amyloid fibril assembly and toxicity. Proc Natl Acad Sci U S A (2007) 1.10
ALAD porphyria is a conformational disease. Am J Hum Genet (2006) 1.09
Abeta aggregation and possible implications in Alzheimer's disease pathogenesis. J Cell Mol Med (2009) 1.09
Amyloid protofilament formation of hen egg lysozyme in highly concentrated ethanol solution. Protein Sci (2000) 1.06
Selective accumulation of aggregation-prone proteasome substrates in response to proteotoxic stress. Mol Cell Biol (2009) 1.05
Dichotomous versus palm-type mechanisms of lateral assembly of amyloid fibrils. Protein Sci (2006) 1.04
Bile acid-induced Mallory body formation in drug-primed mouse liver. Am J Pathol (2002) 1.03
Scrapie-like prion protein accumulates in aggresomes of cyclosporin A-treated cells. EMBO J (2003) 1.03
L-asparaginase-induced antithrombin type I deficiency: implications for conformational diseases. Am J Pathol (2006) 1.03
Silencing GADD153/CHOP gene expression protects against Alzheimer's disease-like pathology induced by 27-hydroxycholesterol in rabbit hippocampus. PLoS One (2011) 1.02
Amyloid in neurodegenerative diseases: friend or foe? Semin Cell Dev Biol (2011) 1.02
Structural characterization of clusterin-chaperone client protein complexes. J Biol Chem (2009) 1.01
Somatic mutations of the L12a gene in V-kappa(1) light chain deposition disease: potential effects on aberrant protein conformation and deposition. Am J Pathol (1999) 1.01
Neuroserpin polymers activate NF-kappaB by a calcium signaling pathway that is independent of the unfolded protein response. J Biol Chem (2009) 1.00
Defective folding and rapid degradation of mutant proteins is a common disease mechanism in genetic disorders. J Inherit Metab Dis (2000) 1.00
The N terminus of the serpin, tengpin, functions to trap the metastable native state. EMBO Rep (2007) 0.97
Molecular chaperones antagonize proteotoxicity by differentially modulating protein aggregation pathways. Prion (2009) 0.97
C1 inhibitor: molecular and clinical aspects. Springer Semin Immunopathol (2005) 0.96
Aggregation of granulocyte-colony stimulating factor in vitro involves a conformationally altered monomeric state. Protein Sci (2005) 0.96
Cold rescue of the thermolabile tailspike intermediate at the junction between productive folding and off-pathway aggregation. Protein Sci (1998) 0.95
Phosphatidylethanolamine enhances amyloid fiber-dependent membrane fragmentation. Biochemistry (2012) 0.95
Graphene oxide as an enzyme inhibitor: modulation of activity of α-chymotrypsin. J Am Chem Soc (2011) 0.94
Mutations in the B1 domain of protein G that delay the onset of amyloid fibril formation in vitro. Protein Sci (2003) 0.94
X-ray crystal structure of MENT: evidence for functional loop-sheet polymers in chromatin condensation. EMBO J (2006) 0.94
Reciprocal efficiency of RNQ1 and polyglutamine detoxification in the cytosol and nucleus. Mol Biol Cell (2009) 0.94
The tempered polymerization of human neuroserpin. PLoS One (2012) 0.93
The role of chaperone-assisted folding and quality control in inborn errors of metabolism: protein folding disorders. J Inherit Metab Dis (2001) 0.91
Microcin amyloid fibrils A are reservoir of toxic oligomeric species. J Biol Chem (2012) 0.91
Identification of human plasma proteins as major clients for the extracellular chaperone clusterin. J Biol Chem (2009) 0.91
Multiple ways to die: delineation of the unfolded protein response and apoptosis induced by Surfactant Protein C BRICHOS mutants. Int J Biochem Cell Biol (2011) 0.91
Association-induced folding of globular proteins. Proc Natl Acad Sci U S A (1998) 0.90
Nonpolar substitution at the C-terminus of the prion protein, a mimic of the glycosylphosphatidylinositol anchor, partially impairs amyloid fibril formation. Biochemistry (2007) 0.89
Fibrillar structure and charge determine the interaction of polyglutamine protein aggregates with the cell surface. J Biol Chem (2012) 0.89
Molecular structure of amyloid fibrils controls the relationship between fibrillar size and toxicity. PLoS One (2011) 0.89
Prion propagation by Hsp40 molecular chaperones. Prion (2009) 0.87
The threads that tie protein-folding diseases. Dis Model Mech (2014) 0.86
Stabilization of a metastable state of Torpedo californica acetylcholinesterase by chemical chaperones. Protein Sci (2003) 0.86
Identification of proteins that modify cataract of mouse eye lens. Proteomics (2008) 0.86
The mechanism of enhanced insulin amyloid fibril formation by NaCl is better explained by a conformational change model. PLoS One (2011) 0.86
Expression of hereditary hemochromatosis C282Y HFE protein in HEK293 cells activates specific endoplasmic reticulum stress responses. BMC Cell Biol (2007) 0.86
Biotic acts of antibiotics. Front Microbiol (2013) 0.86
Aggregates of denatured proteins stimulate nitric oxide and superoxide production in macrophages. Inflamm Res (2009) 0.85
Polyglutamine misfolding in yeast: toxic and protective aggregation. Prion (2011) 0.85
Reversible formation of on-pathway macroscopic aggregates during the folding of maltose binding protein. Protein Sci (2001) 0.85
Pressure-jump-induced kinetics reveals a hydration dependent folding/unfolding mechanism of ribonuclease A. Biophys J (2006) 0.85
Apolipoprotein E polymorphism in patients with cataract. Br J Ophthalmol (2004) 0.85
Alpha-1-antitrypsin deficiency in Serbian adults with lung diseases. Genet Test Mol Biomarkers (2012) 0.85
Beta-sheet containment by flanking prolines: molecular dynamic simulations of the inhibition of beta-sheet elongation by proline residues in human prion protein. Biophys J (2006) 0.85
Membrane Incorporation, Channel Formation, and Disruption of Calcium Homeostasis by Alzheimer's β-Amyloid Protein. Int J Alzheimers Dis (2011) 0.85
Conformational transitions in beta-lactoglobulin induced by cationic amphiphiles: equilibrium studies. Biophys J (2004) 0.85
Natural genetic variation determines susceptibility to aggregation or toxicity in a C. elegans model for polyglutamine disease. BMC Biol (2013) 0.84
Molecular Pathological Classification of Neurodegenerative Diseases: Turning towards Precision Medicine. Int J Mol Sci (2016) 0.84
Protein misfolding and the serpinopathies. Prion (2007) 0.83
Basal and stress-induced Hsp70 are modulated by ataxin-3. Cell Stress Chaperones (2012) 0.83
The Hsp70/90 cochaperone, Sti1, suppresses proteotoxicity by regulating spatial quality control of amyloid-like proteins. Mol Biol Cell (2013) 0.83
Preventing serpin aggregation: the molecular mechanism of citrate action upon antitrypsin unfolding. Protein Sci (2008) 0.83
Polyglutamine-rich suppressors of huntingtin toxicity act upstream of Hsp70 and Sti1 in spatial quality control of amyloid-like proteins. PLoS One (2014) 0.83
Accumulation of mutant neuroserpin precedes development of clinical symptoms in familial encephalopathy with neuroserpin inclusion bodies. Am J Pathol (2007) 0.82
Functional and dysfunctional conformers of human neuroserpin characterized by optical spectroscopies and Molecular Dynamics. Biochim Biophys Acta (2014) 0.82
Self-organization and regulation of intrinsically disordered proteins with folded N-termini. PLoS Biol (2011) 0.82
The roles of helix I and strand 5A in the folding, function and misfolding of α1-antitrypsin. PLoS One (2013) 0.82
Structure of GroEL in complex with an early folding intermediate of alanine glyoxylate aminotransferase. J Biol Chem (2010) 0.82
MORPHEEINS - A NEW PATHWAY FOR ALLOSTERIC DRUG DISCOVERY. Open Conf Proc J (2010) 0.82
Folding of the prion peptide GGGTHSQW around the copper(II) ion: identifying the oxygen donor ligand at neutral pH and probing the proximity of the tryptophan residue to the copper ion. J Biol Inorg Chem (2008) 0.82
[Amyloid and amyloidoses]. Pathologe (2009) 0.82
Dissection of a beta-barrel motif leads to a functional dimer: the case of the intestinal fatty acid binding protein. Protein Sci (2009) 0.81
Selenomethionine incorporation into amyloid sequences regulates fibrillogenesis and toxicity. PLoS One (2011) 0.81
The serpins are an expanding superfamily of structurally similar but functionally diverse proteins. Evolution, mechanism of inhibition, novel functions, and a revised nomenclature. J Biol Chem (2001) 4.81
Evaluation of COPD Longitudinally to Identify Predictive Surrogate End-points (ECLIPSE). Eur Respir J (2008) 4.53
Intraneuronal Abeta, non-amyloid aggregates and neurodegeneration in a Drosophila model of Alzheimer's disease. Neuroscience (2005) 2.54
Clinical outcome in relation to care in centres specialising in cystic fibrosis: cross sectional study. BMJ (1998) 2.22
Siblings of patients with severe chronic obstructive pulmonary disease have a significant risk of airflow obstruction. Am J Respir Crit Care Med (2001) 2.11
Familial dementia caused by polymerization of mutant neuroserpin. Nature (1999) 1.88
A kinetic mechanism for the polymerization of alpha1-antitrypsin. J Biol Chem (1999) 1.70
Inhibitory conformation of the reactive loop of alpha 1-antitrypsin. Nat Struct Biol (1996) 1.66
CTLA4 gene polymorphisms are associated with chronic bronchitis. Eur Respir J (2009) 1.62
Polymorphisms in the superoxide dismutase-3 gene are associated with emphysema in COPD. COPD (2010) 1.60
Heteropolymerization of S, I, and Z alpha1-antitrypsin and liver cirrhosis. J Clin Invest (1999) 1.60
Topography of a 2.0 A structure of alpha1-antitrypsin reveals targets for rational drug design to prevent conformational disease. Protein Sci (2000) 1.58
Inactive conformation of the serpin alpha(1)-antichymotrypsin indicates two-stage insertion of the reactive loop: implications for inhibitory function and conformational disease. Proc Natl Acad Sci U S A (2000) 1.54
Lung polymers in Z alpha1-antitrypsin deficiency-related emphysema. Am J Respir Cell Mol Biol (1998) 1.47
Impact of non-linear smoking effects on the identification of gene-by-smoking interactions in COPD genetics studies. Thorax (2010) 1.46
Pathogenic alpha 1-antitrypsin polymers are formed by reactive loop-beta-sheet A linkage. J Biol Chem (2000) 1.43
Neuroserpin: a serpin to think about. Cell Mol Life Sci (2006) 1.32
Wild-type alpha 1-antitrypsin is in the canonical inhibitory conformation. J Mol Biol (1998) 1.26
A 2.6 A structure of a serpin polymer and implications for conformational disease. J Mol Biol (1999) 1.26
Prevention of polymerization of M and Z alpha1-Antitrypsin (alpha1-AT) with trimethylamine N-oxide. Implications for the treatment of alpha1-at deficiency. Am J Respir Cell Mol Biol (2001) 1.17
Genetics and respiratory disease. 2. Alpha 1-antitrypsin deficiency, cirrhosis and emphysema. Thorax (1998) 1.17
Smoking related COPD and facial wrinkling: is there a common susceptibility? Thorax (2006) 1.15
Alpha-helix targeting reduces amyloid-beta peptide toxicity. Proc Natl Acad Sci U S A (2009) 1.11
Mechanisms of emphysema in alpha1-antitrypsin deficiency: molecular and cellular insights. Eur Respir J (2009) 1.07
Alpha1-antitrypsin deficiency alleles and the Taq-I G-->A allele in cystic fibrosis lung disease. Eur Respir J (1998) 1.07
Dietary antioxidants and asthma in adults. Thorax (2006) 1.07
Structural explanation for the deficiency of S alpha 1-antitrypsin. Nat Struct Biol (1996) 1.04
ANCA-associated vasculitis is linked to carriage of the Z allele of α₁ antitrypsin and its polymers. Ann Rheum Dis (2011) 1.04
Implications for function and therapy of a 2.9 A structure of binary-complexed antithrombin. J Mol Biol (1998) 1.03
Polymerization of plasminogen activator inhibitor-1. J Biol Chem (2000) 1.00
Plasma and CSF serpins in Alzheimer disease and dementia with Lewy bodies. Neurology (2007) 0.99
Candidate genes for COPD in two large data sets. Eur Respir J (2010) 0.96
Probing serpin reactive-loop conformations by proteolytic cleavage. Biochem J (1996) 0.95
Mutations which impede loop/sheet polymerization enhance the secretion of human alpha 1-antitrypsin deficiency variants. J Biol Chem (1995) 0.95
The effect of the Z mutation on the ability of alpha 1-antitrypsin to prevent neutrophil mediated tissue damage. Biochim Biophys Acta (1994) 0.93
What can naturally occurring mutations tell us about the pathogenesis of COPD? Thorax (2009) 0.92
Childhood smoking is an independent risk factor for obstructive airways disease in women. Thorax (2004) 0.90
The house dust mite allergen Der p1 catalytically inactivates alpha 1-antitrypsin by specific reactive centre loop cleavage: a mechanism that promotes airway inflammation and asthma. Biochem Biophys Res Commun (1996) 0.89
Latent alpha1-antichymotrypsin. A molecular explanation for the inactivation of alpha1-antichymotrypsin in chronic bronchitis and emphysema. J Biol Chem (1998) 0.89
The endoplasmic reticulum stress marker CHOP predicts survival in malignant mesothelioma. Br J Cancer (2013) 0.88
Anti-neutrophil cytoplasmic antibodies (ANCA) against bactericidal/permeability-increasing protein (BPI) and cystic fibrosis lung disease. Clin Exp Immunol (1999) 0.86
Alpha-1 antitrypsin deficiency alleles and severe cystic fibrosis lung disease. Thorax (1998) 0.86
Alpha 1-antitrypsin deficiency. A conformational disease. Chest (1996) 0.84
Potential role of recombinant secretory leucoprotease inhibitor in the prevention of neutrophil mediated matrix degradation. Thorax (1994) 0.83
Genetic association between human chitinases and lung function in COPD. Hum Genet (2011) 0.82
The effects of weekly augmentation therapy in patients with PiZZ α1-antitrypsin deficiency. Int J Chron Obstruct Pulmon Dis (2012) 0.81
The effect of sequence variations within the coding region of the C1 inhibitor gene on disease expression and protein function in families with hereditary angio-oedema. J Med Genet (2003) 0.79
Effect of non-steroidal anti-inflammatory drugs on neutrophil chemotaxis--an in vitro and in vivo study. Br J Rheumatol (1990) 0.78
Association of alpha(1)-antichymotrypsin deficiency with milder lung disease in patients with cystic fibrosis. Thorax (2001) 0.78
Alpha-1-antitrypsin deficiency, the serpinopathies and conformational disease. J R Coll Physicians Lond (2000) 0.77
Secondary genetic factors in cystic fibrosis lung disease. Thorax (2000) 0.75
Repeated insertion of foreign bodies into the tracheobronchial tree via tracheostomy. J Laryngol Otol (1993) 0.75
Conformational changes in serpins and the mechanism of alpha 1-antitrypsin deficiency. Am J Respir Crit Care Med (1994) 0.75
Lung volume reduction surgery: where are we now? Chron Respir Dis (2004) 0.75
Identification of DNA polymorphisms associated with the V type alpha1-antitrypsin gene. Biochim Biophys Acta (1999) 0.75
A novel polymorphism (471C-->T) in alpha-1-antitrypsin in a patient with asthma. Hum Mutat (2001) 0.75